Premium
How close are disease‐modifying drugs for osteoarthritis?
Author(s) -
Greener Mark
Publication year - 2021
Publication title -
prescriber
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.106
H-Index - 3
eISSN - 1931-2253
pISSN - 0959-6682
DOI - 10.1002/psb.1884
Subject(s) - medicine , osteoarthritis , disease , rheumatoid arthritis , pathogenesis , intensive care medicine , bioinformatics , alternative medicine , immunology , pathology , biology
Progress in the development of disease‐modifying drugs for osteoarthritis has been hampered by a lack of understanding of the pathogenesis of the disease and how it differs from rheumatoid arthritis. However, more recent research in this field has identified several promising therapeutic targets.